Clinical-stage biotechnology company PharmAust (ASX: PAA) has reported positive results from ongoing product stability and shelf-life testing of its lead anti-cancer drug candidate monepantel in tablet form.
Hyperosteogeny is a common orthopedic disease, which seriously threatens human health. Hyperosteogeny is a chronic strain disease. Its main manifestation is joint pain. If it is serious, it can’t even walk. So, what are the symptoms of hyperosteogeny?